← FDA DRUG APPROVALS

FDA ANDA · ANDA201311

FEXOFENADINE HYDROCHLORIDE

Sponsor: P AND L

APPLICATION
ANDA201311
TYPE
ANDA
ORIGINAL APPROVAL
2012-07-25
LATEST ACTION
2020-03-16
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

FEXOFENADINE HYDROCHLORIDEDiscontinued
FEXOFENADINE HYDROCHLORIDE 30MG/5ML · SUSPENSION · ORAL

Approval history

2020-03-16Labeling · Supplement 3 · standardAP
2016-05-27Manufacturing (CMC) · Supplement 1 · unknownAP
2012-07-25Not Applicable · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →